The scientific sessions of the Jeddah Pharmacy Conference 2026 continued into their second day on Thursday, with leading pharmacists, physicians, and researchers convening in Jeddah to examine specialized topics spanning chronic diseases, therapeutic and pharmaceutical practices, healthcare developments, and advances in diagnosis and treatment, as reported by the Saudi Press Agency (SPA). The second day’s program placed particular emphasis on “Diabetic Retinopathy and Retinal Diseases,” covering screening protocols, prevention strategies, disease stages, and treatment options, while also exploring glaucoma management and dry eye through reviews of the latest developments in diagnosis, treatment, and related clinical practices.
The two-day gathering, held in Saudi Arabia’s second-largest city and a longstanding commercial and medical hub on the Red Sea coast, has drawn attention for the breadth of its scientific program. Across the conference, sessions have addressed chronic diseases, eye health, and advances in treatment, reflecting the wide range of scientific fields included in the agenda. Isn’t it significant that a single national conference can convene specialists across so many disciplines at once? The event underscores the Kingdom’s expanding capacity to host specialized medical dialogue that serves both Saudi practitioners and the wider regional healthcare community.
How Does the Jeddah Pharmacy Conference Fit Into Saudi Arabia’s Healthcare Calendar?
The Jeddah Pharmacy Conference 2026 arrives at a moment when Saudi Arabia is investing heavily in the quality, accessibility, and sophistication of its health services. Under the Health Sector Transformation Program, one of the central pillars of Saudi Vision 2030, the Kingdom has been restructuring care delivery, expanding preventive medicine, and strengthening the role of pharmacists within multidisciplinary care teams. The conference reflects that direction by giving pharmaceutical professionals a dedicated platform to exchange clinical knowledge with ophthalmologists, internists, and other specialists.
Pharmacists in Saudi Arabia have seen their responsibilities broaden considerably in recent years. Beyond dispensing medications, they now contribute to medication therapy management, patient counseling, and chronic disease follow-up, particularly for conditions such as diabetes and hypertension that require long-term pharmaceutical oversight. A conference that pairs pharmacy practice with ophthalmic disease management is therefore more than an academic exercise; it mirrors how care is actually delivered in modern Saudi hospitals and clinics, where pharmacists and physicians coordinate closely on treatment plans.
The choice of Jeddah as the host city also carries meaning. The city is home to major tertiary hospitals, research centers, and medical universities, and it serves as a gateway for pilgrims and travelers passing through the Kingdom. Hosting a specialized scientific conference there reinforces Jeddah’s position as a center of medical education and professional development, complementing Riyadh’s role as the administrative capital of Saudi health policy.
What Made Diabetic Retinopathy the Focus of the Second Day?
The second day’s sessions addressed “Diabetic Retinopathy and Retinal Diseases,” covering screening, prevention, disease stages, and treatment options. Diabetic retinopathy remains one of the most common complications of diabetes and a leading cause of preventable vision loss worldwide, which explains why it received dedicated attention. In Saudi Arabia, where diabetes prevalence is among the higher rates in the region, early detection through systematic retinal screening has become a public health priority.
Conference participants reviewed how screening programs can identify retinal changes before patients notice symptoms, when interventions are most effective. Discussions covered the progression of the disease through its stages and the range of treatment options available, from laser therapy to intravitreal injections and newer pharmacological approaches. Because pharmacists are often the first point of contact for patients managing diabetes, their role in encouraging regular eye examinations and adherence to treatment was highlighted as an essential link in the care chain.
The program also explored glaucoma management and dry eye, reviewing the latest developments in diagnosis, treatment, and related clinical practices. Glaucoma, sometimes called the silent thief of sight, requires lifelong management, while dry eye has become increasingly prevalent in arid climates and among populations with high screen exposure. Together, these topics reflect a program that balances high-impact systemic disease with common quality-of-life conditions affecting millions across the region.
Which Therapeutic and Pharmaceutical Practices Were Highlighted?
Beyond ophthalmology, the conference’s scientific sessions examined therapeutic and pharmaceutical practices more broadly, including advances in diagnosis and treatment across chronic diseases. These sessions provided a forum for reviewing evidence-based prescribing, medication safety, and the integration of new therapies into existing treatment pathways. Such discussions matter because they translate research findings into practical guidance that clinicians can apply immediately in hospitals, clinics, and community pharmacies.
Participants also considered healthcare developments that are reshaping professional practice in the Kingdom. The ongoing digital transformation of Saudi health services, including electronic health records, telepharmacy, and clinical decision-support tools, has changed how medications are prescribed, monitored, and dispensed. Conferences like this one allow practitioners to compare experiences, identify best practices, and align their work with national standards set by the Ministry of Health and the Saudi Food and Drug Authority.
Continuing professional education is another core function of the event. For pharmacists and physicians in Saudi Arabia, maintaining licensure and staying current with therapeutic advances requires regular participation in accredited scientific meetings. The Jeddah Pharmacy Conference helps meet that need while also creating opportunities for younger practitioners, residents, and students to engage directly with senior specialists and researchers.
What Does the Conference Mean for International and Regional Collaboration?
The presence of specialized scientific sessions in Jeddah signals Saudi Arabia’s growing integration into global medical knowledge networks. Regional and international experts frequently participate in Saudi conferences, sharing findings and building research partnerships that extend beyond the event itself. For international observers, the conference offers a window into how the Kingdom is developing its pharmaceutical workforce and aligning clinical practice with globally recognized standards.
Regional collaboration is equally important. Gulf and wider Middle Eastern countries face similar challenges in chronic disease management, and conferences hosted in Saudi Arabia create natural opportunities for cross-border dialogue on screening programs, treatment protocols, and public health campaigns. By convening these discussions, the Kingdom positions itself as a constructive partner in regional health improvement, consistent with its broader diplomatic and humanitarian engagement.
For international pharmacists and healthcare companies, the event also serves as a point of contact with one of the region’s largest and fastest-modernizing healthcare markets. Saudi Arabia’s pharmaceutical sector is expanding, with local manufacturing, research, and distribution capabilities growing under Vision 2030. Scientific meetings help build the professional relationships that support these developments over the long term.
Why Do These Sessions Matter for Economic and Strategic Priorities?
Health is increasingly recognized as a strategic asset in Saudi Arabia’s economic diversification agenda. A healthier population supports productivity, reduces long-term care costs, and contributes to the quality of life that Vision 2030 seeks to enhance. Conferences that improve clinical knowledge and early detection of complications such as diabetic retinopathy therefore have economic value that extends well beyond the lecture halls, helping to avert vision loss that would otherwise reduce workforce participation and independence.
The event also reinforces the growth of Saudi Arabia’s life sciences and healthcare industries. As the Kingdom invests in local pharmaceutical manufacturing, research and development, and specialized medical services, a well-trained and continuously educated workforce becomes essential. Scientific sessions that connect pharmacy practice with ophthalmology and chronic disease care strengthen the human capital base on which these industries depend.
In addition, hosting specialized conferences contributes to the broader events and tourism economy that Saudi Arabia is actively developing. Jeddah’s hospitality, transport, and conference infrastructure benefit from medical meetings, while visitors gain exposure to the city’s cultural and commercial offerings. This aligns with national efforts to attract business and professional tourism alongside traditional leisure and religious travel.
How Does the Jeddah Pharmacy Conference Align With Vision 2030?
The Jeddah Pharmacy Conference 2026 aligns directly with the Health Sector Transformation Program under Saudi Vision 2030, which aims to improve access to care, elevate clinical quality, and promote prevention. By focusing on chronic diseases, eye health, and advances in treatment, the conference supports the national shift toward earlier diagnosis and more effective management of conditions that affect large segments of the population. It also reflects the Kingdom’s commitment to evidence-based practice and continuous professional development.
More broadly, the event illustrates how Saudi Arabia is building a knowledge-driven healthcare ecosystem. Universities, hospitals, regulatory bodies, and professional societies are working together to raise standards and foster research, while international and regional participation brings new ideas into the Kingdom. For a global audience, the message is clear: Saudi Arabia is not only investing in hospitals and technology, but also in the people and scientific exchange that make high-quality care possible. As the sessions continue, the conference stands as another example of the Kingdom’s forward-looking vision for health, prosperity, and global engagement.
20 Questions
Q1. What is the Jeddah Pharmacy Conference 2026?
A1. It is a specialized scientific conference held in Jeddah, Saudi Arabia, that brings together pharmacists, physicians, and researchers to discuss chronic diseases, therapeutic practices, healthcare developments, and advances in diagnosis and treatment, as reported by the Saudi Press Agency.
Q2. When did the second day of the conference take place?
A2. The scientific sessions continued on Thursday into the second day of the two-day event, with the program covering specialized topics and reflecting the range of scientific fields addressed, according to official Saudi information.
Q3. What was the main focus of the second day’s sessions?
A3. The second day addressed “Diabetic Retinopathy and Retinal Diseases,” covering screening, prevention, disease stages, and treatment options, while also exploring glaucoma management and dry eye and related clinical practices.
Q4. Why is diabetic retinopathy an important topic in Saudi Arabia?
A4. Diabetes is prevalent in the Kingdom, and diabetic retinopathy is a leading cause of preventable vision loss. Early screening and treatment are therefore public health priorities supported by Saudi health authorities.
Q5. What aspects of diabetic retinopathy were discussed?
A5. Sessions covered screening methods, prevention strategies, the stages of disease progression, and treatment options, giving participants a comprehensive view of how to detect and manage the condition effectively in clinical settings.
Q6. What other eye conditions were reviewed at the conference?
A6. Glaucoma management and dry eye were examined, with reviews of the latest developments in diagnosis, treatment, and related clinical practices, complementing the focus on retinal diseases.
Q7. How do pharmacists contribute to eye health?
A7. Pharmacists support patients managing chronic conditions such as diabetes by encouraging regular eye examinations, promoting medication adherence, and coordinating with physicians on treatment plans that protect vision.
Q8. What broader topics did the conference sessions cover?
A8. Over the two days, sessions covered chronic diseases, eye health, and advances in treatment, reflecting the wide range of scientific fields included in the program and the multidisciplinary nature of modern care.
Q9. Who participated in the Jeddah Pharmacy Conference 2026?
A9. The conference brought together pharmacists, physicians, researchers, and other healthcare professionals, creating a platform for specialists to exchange knowledge and review the latest clinical developments in their fields.
Q10. How does the conference support continuing education?
A10. It provides accredited scientific sessions that help practitioners stay current with therapeutic advances, meet professional development requirements, and engage directly with senior specialists and researchers from Saudi Arabia and abroad.
Q11. What is the significance of holding the event in Jeddah?
A11. Jeddah is a major medical, commercial, and cultural hub with leading hospitals and universities. Hosting the conference there reinforces the city’s role in medical education and professional development within the Kingdom.
Q12. How does the conference relate to Saudi Vision 2030?
A12. It aligns with the Health Sector Transformation Program, which aims to improve care quality, expand prevention, and promote evidence-based practice, supporting the broader goals of Saudi Vision 2030 for health and quality of life.
Q13. What role does the Saudi Press Agency play in reporting the event?
A13. The Saudi Press Agency is the official national news agency that reported the conference sessions, providing authoritative coverage of the scientific program and its topics to domestic and international audiences.
Q14. Are there opportunities for international collaboration?
A14. Yes. Saudi medical conferences typically include regional and international experts, fostering research partnerships and professional networks that extend beyond the event and support global knowledge exchange.
Q15. What economic benefits can result from such conferences?
A15. They strengthen the healthcare workforce, support the life sciences sector, and contribute to business and professional tourism, all of which align with Saudi Arabia’s economic diversification goals under Vision 2030.
Q16. How does the conference address chronic diseases?
A16. Sessions examine therapeutic and pharmaceutical practices for chronic conditions, emphasizing evidence-based prescribing, medication safety, and long-term management strategies that improve patient outcomes and reduce complications.
Q17. What advances in diagnosis and treatment were highlighted?
A17. Participants reviewed new approaches in retinal disease management, glaucoma care, and dry eye treatment, as well as broader therapeutic developments, helping clinicians apply the latest evidence in daily practice.
Q18. How does the event support Saudi Arabia’s healthcare workforce?
A18. By offering specialized education and networking, the conference helps pharmacists and physicians enhance their skills, which strengthens the human capital needed for the Kingdom’s expanding health and life sciences industries.
Q19. What message does the conference send to global observers?
A19. It demonstrates Saudi Arabia’s commitment to high-quality healthcare, scientific exchange, and international engagement, showing that the Kingdom is investing in both medical infrastructure and the professionals who deliver care.
Q20. What comes next after the Jeddah Pharmacy Conference 2026?
A20. The knowledge shared will inform clinical practice across Saudi hospitals and pharmacies, while the professional connections formed will support future research, collaboration, and continued progress toward Vision 2030 health goals.
Reader Feedback
We value your thoughts. Please share your feedback on this article.
Your feedback helps us improve our coverage.